Status:

COMPLETED

Nutrition Intervention During Chemotherapy

Lead Sponsor:

Texas A&M University

Conditions:

Cancer Patients Receiving Chemotherapy or Chemoradiotherapy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Weight loss and muscle wasting commonly occurs in patients with cancer, negatively influencing their quality of life, treatment response and survival. Weight loss has been reported as a side effect of...

Detailed Description

For the cancer subjects, the study involves 1 test day prior to a chemotherapy treatment, a 10-week (± 2 weeks) nutritional intervention period at home starting the first day of the chemotherapy treat...

Eligibility Criteria

Inclusion

  • Inclusion criteria cancer subjects:
  • Diagnosed with cancer
  • Scheduled for chemotherapy or chemoradiotherapy
  • Ability to sign informed consent
  • Age 18y and older
  • Ability to lie in supine position for 7 hours
  • Inclusion criteria healthy subjects:
  • Healthy male or female according to the investigator's or appointed staff's judgment
  • Age 18 years or older
  • No diagnosis of cancer
  • Exclusion Criteria
  • Presence of fever within the last 3 days
  • BMI \> 38 kg/m2 (healthy controls only)
  • Untreated metabolic diseases including hepatic or renal disorder
  • Presence of acute illness or metabolically unstable chronic illness
  • Use of protein or amino acid containing nutritional supplements within 5 days of first test day
  • Known hypersensitivity to fish and/or shellfish, Swanson EFAs Super EPA Fish oil or any of its ingredients, Swanson EFAs Certified Organic Extra Virgin Olive oil or any of its ingredients, Smartfish Nutrifriend or any of its ingredients (Cancer subjects only)
  • Use of supplements containing EPA+DHA 3 months prior to the first test day
  • Any other condition according to the PI or nurse that would interfere with the study or safety of the patient
  • Failure to give informed consent
  • (Possible) pregnancy

Exclusion

    Key Trial Info

    Start Date :

    April 26 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    November 3 2015

    Estimated Enrollment :

    31 Patients enrolled

    Trial Details

    Trial ID

    NCT01871350

    Start Date

    April 26 2013

    End Date

    November 3 2015

    Last Update

    September 30 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Texas A&M University

    College Station, Texas, United States, 77843